Beta-adrenoceptor Blockers. An Update on Their Role in Acute Myocardial Infarction
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Benfield P, Clissold S, Brogden R Drugs. 1986; 31(5):376-429.
PMID: 2940080 DOI: 10.2165/00003495-198631050-00002.
Nattel S, Gagne G, Pineau M Clin Pharmacokinet. 1987; 13(5):293-316.
PMID: 2891461 DOI: 10.2165/00003088-198713050-00002.
References
1.
Norris R, Clarke E, Sammel N, Smith W, Williams B
. Protective effect of propranolol in threatened myocardial infarction. Lancet. 1978; 2(8096):907-9.
DOI: 10.1016/s0140-6736(78)91628-8.
View
2.
Jurgensen J, Frederiksen J, Hansen D
. Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol. Br Heart J. 1981; 45(5):583-8.
PMC: 482568.
DOI: 10.1136/hrt.45.5.583.
View
3.
Olsson G, Hjemdahl P, Rehnqvist N
. Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease. Am Heart J. 1984; 108(3 Pt 1):454-62.
DOI: 10.1016/0002-8703(84)90408-3.
View
4.
Nordrehaug J, von der Lippe G
. Hypokalaemia and ventricular fibrillation in acute myocardial infarction. Br Heart J. 1983; 50(6):525-9.
PMC: 481454.
DOI: 10.1136/hrt.50.6.525.
View
5.
Olsson G, Rehnqvist N, Sjogren A, Erhardt L, LUNDMAN T
. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. J Am Coll Cardiol. 1985; 5(6):1428-37.
DOI: 10.1016/s0735-1097(85)80360-0.
View